Xiaoying Quan,Xiaoyan Chen,Lei Lei,Xiaoli Jia,Chunzhi Wu,Bin Ye. Case report of a mixed pulmonary large cell neuroendocrine carcinoma. Oncol Transl Med, 2022, 8: 311-313. |
Case report of a mixed pulmonary large cell neuroendocrine carcinoma |
Received:January 17, 2022 Revised:December 20, 2022 |
View Full Text View/Add Comment Download reader |
KeyWord:pulmonary large cell neuroendocrine carcinoma; pulmonary adenocarcinoma; diagnosis; treatment |
Author Name | Affiliation | E-mail | Xiaoying Quan | Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu | 1193084163@qq.com | Xiaoyan Chen | Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu | | Lei Lei | Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu | | Xiaoli Jia | Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu | | Chunzhi Wu | Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu | | Bin Ye | Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu | 354539616@qq.com |
|
Hits: 1253 |
Download times: 1401 |
Abstract: |
A 57 year-old male patient was found to have a lesion in the middle lobe of his right lung using chest
computed tomography (CT). Tumor cells were detected, and surgical excision was performed. The
patient was diagnosed with mixed large cell neuroendocrine carcinoma, and underwent six cycles of a
chemotherapy regimen comprising etoposide combined with cisplatin. Genetic testing revealed an EGFR
mutation, which prompted oxitinib-targeted therapy. To date, no signs of recurrence or metastasis have
been reported. |
Close |
|
|
|